| Name | Title | Contact Details |
|---|
MSI Methylation Sciences Inc. (“MSI”) is a clinical-stage pharmaceutical company focused on developing new products based on molecules which have clinical proof of concept but which have yet to be exploited in the major pharmaceutical markets. MSI`s focus is in the CNS space where clinical proof of concept is key to reducing the drug development risk. Our lead product candidate, Strada™, is based upon Ademetionine, a naturally occurring molecule produced throughout the body, where it plays a vital role in the one-carbon cycle. Our disease indication is Major Depressive Disorder (MDD).
New York State Office of Mental Health is a Albany, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Maverick Therapeutics is pioneering the next generation of redirected T-cell targeted immunotherapies. Mavericks highly innovative platform, COBRA™, is the most advanced bispecific T-cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.
Absolute Total Care is a Columbia, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NY CREATES is a world leading R&D, innovation hub and commercialization facilitator that works with researchers in industry, academia and national labs to leverage the state of the art infrastructure in upstate New York and to partner with NY CREATES’ ...